Davidson Kempner Capital Management »

Bridgebio Pharma shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $30M 30M 0.98
2025-06-30 $28M 30M 0.93
2025-03-31 $27M 30M 0.90
2024-12-31 $21M 25M 0.85

More positions owned by Davidson Kempner Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Verona Pharma Sponsored Ads (VRNA)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Pdd Holdings Note 12/0 (Principal)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Uber Technologies Note 0.875%12/0 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Amazon (AMZN)
Arko Corp (ARKO)
Rivian Automotive Note 4.625% 3/1 (Principal)
Redfin Corp Note 0.500% 4/0 (Principal)
NVIDIA Corporation (NVDA)
Snowflake Note 10/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Bridgebio Pharma

Linden Advisors
Wolverine Asset Management
Camden Asset Management
Sona Asset Management
Ing Investment Management
Steelhead Partners
Davidson Kempner Capital Management
MacKay Shields
D. E. Shaw & Co
Jump Financial
Wells Fargo & Company
Advent Capital Management
Laurion Capital Management
State Street Corporation
Lazard Asset Management

View all funds holding Bridgebio Pharma